- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03649256
Deficient Lower Segment Cesarean Section Scar, Does the Type of Suture Matter?
In recent years there has been a significant increase in cesarean sections. This is not without complication in subsequent pregnancies such as placenta previa, placenta accrete, scar pregnancy, dehiscence or uterine rupture. Uterine rupture during trial of labor after cesarean section is an uncommon but potentially catastrophic, life threatening event. It is thus of importance if the investigators were able to predict the risk of uterine rupture. Imaging studies including ultrasound, hysterography and sonohysterography have been used to evaluate the scar from a prior cesarean before pregnancy, there is no consensus as to which of them is the preferred method but it is known that cesarean section scars can be detected reliably by ultrasound imaging. Previous studies have shown that sonographic lower uterine segment thickness is a strong predictor for uterine scar defect and could represent a high risk of uterine rupture during a trial of labor in women with prior cesarean section. There is a likely association between large defects in the scar after cesarean delivery detected by transvaginal ultrasonography in non pregnant women and uterine rupture or dehiscence in subsequent pregnancy.
The knotless barbed suture was FDA approved in 2004. Knotless barbed sutures are monofilament sutures with barbs cut into them. These sutures self-anchor, maintaining tissue approximation without the need for surgical knots.
The objective of this study is to determine whether there is a difference in the lower uterine segment thickness between uterine scars sutured with two types of sutures, to determine whether there is a difference in the size of the scar defects.
Methods: Two hundred and two women will undergo transvaginal ultrasound examination 3 and 6 months after delivery: 101 women will have undergone cesarean section in which the Vicryl suture was used, 101 women will have undergone cesarean section in which the KBS suture was used. The ultrasound examiner will be blinded to the use of the suture. The investigators will measure the myometrial thickness 3 months and 6 months after the delivery and compare the results between the 2 groups.
The assumption is that the findings of the study will be useful in counseling concerning Trial of Labor after Cesarean (TOLAC). To the best of the investigators' knowledge, there are no published data on the risk of uterine rupture predicted based on the myometrial thickness measured in the non-pregnant patient when the knotless barbed suture was used in the cesarean section. Previous studies have examined the applicability of low uterine segment measurement in the third trimester in the prediction of a uterine defect during trial of labor
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Post Cesarean section
Exclusion Criteria:
- Non low- transverse incision, after myomectomy, pregnancy
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Conventional suture
closure of uterine incision with conventional suture (Vicryl, Ethicon)
|
Ultrasound measurement of thickness of the uterine scar at 3 and 6 months
|
Barbed suture
closure of uterine incision with barbed suture (Stratafix, Ethicon)
|
Ultrasound measurement of thickness of the uterine scar at 3 and 6 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Uterine Thickness
Time Frame: 6 months
|
uterine myometrial thickness as measured by ultrasound
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Uterine Thickness
Time Frame: 3 months
|
uterine myometrial thickness as measured by ultrasound
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ZIV-0085-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on 2 Arms, Conventional Suture, Barbed Suture
-
Xijing HospitalRecruitingCervical Spinal Stenosis | Posterior Cervical Spine Surgery | Barbed SutureChina
Clinical Trials on Thickness of lower uterine segment scar
-
Cairo UniversityUnknown
-
Martin-Luther-Universität Halle-WittenbergOtto-von-Guericke University MagdeburgCompletedScar; Previous Cesarean Section | Complications; Cesarean Section, Wound, DehiscenceGermany
-
Shu-Qin ChenUnknownQuality of Life | Sexual ActivityChina
-
Tanta UniversityCompletedCesarean Section; Dehiscence | Cesarean Wound; Dehiscence | Cesarean Scar NicheEgypt
-
Uskudar UniversityCompleted
-
Ain Shams Maternity HospitalCompleted
-
Cairo UniversityRecruiting
-
Cairo UniversityCompletedIntraoperative BleedingEgypt
-
Vanderbilt UniversityWithdrawnCongenital Heart DiseaseUnited States
-
Ciceri FabioCompletedMyelodysplastic Syndromes | Fungal Infection | Graft Vs Host Disease | Leukemia, Acute | Transplant-Related Hematologic MalignancyItaly